126 related articles for article (PubMed ID: 7721437)
1. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670.
Douglas SA; Gellai M; Ezekiel M; Feuerstein GZ; Elliott JD; Ohlstein EH
Hypertension; 1995 Apr; 25(4 Pt 2):818-22. PubMed ID: 7721437
[TBL] [Abstract][Full Text] [Related]
2. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension.
Douglas SA; Gellai M; Ezekiel M; Ohlstein EH
J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556
[TBL] [Abstract][Full Text] [Related]
3. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
Bunting MW; Widdop RE
Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
[TBL] [Abstract][Full Text] [Related]
4. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP.
Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M
J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats.
Ohlstein EH; Douglas SA; Ezekiel M; Gellai M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S321-4. PubMed ID: 7509976
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.
Bird JE; Moreland S; Waldron TL; Powell JR
Hypertension; 1995 Jun; 25(6):1191-5. PubMed ID: 7768562
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 2000 Dec; 131(8):1732-8. PubMed ID: 11139453
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
[TBL] [Abstract][Full Text] [Related]
11. Interaction between endothelin and nitric oxide in sympathetic nerve modulation in hypertensive rats.
Kumagai H; Suzuki H; Ichikawa M; Nishizawa M; Oshima N; Saruta T
Hypertens Res; 1997 Mar; 20(1):35-42. PubMed ID: 9101311
[TBL] [Abstract][Full Text] [Related]
12. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension.
Balakrishnan SM; Gopalakrishnan V; McNeill JR
Eur J Pharmacol; 1997 Sep; 334(1):55-60. PubMed ID: 9346328
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
[TBL] [Abstract][Full Text] [Related]
14. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
[TBL] [Abstract][Full Text] [Related]
15. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive action of amiodarone in spontaneously hypertensive rats.
Dias Da Silva VJ; Cavalcante Viana PC; de Melo Alves R; Salgado HC; Montano N; Fazan R
Hypertension; 2001 Sep; 38(3 Pt 2):597-601. PubMed ID: 11566938
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of chronic i.v. administration of 5-carboxamidotryptamine in spontaneously hypertensive rats.
Balasubramaniam G; Lee HS; Mah SC
Eur J Pharmacol; 1993 Jun; 237(2-3):207-13. PubMed ID: 8365451
[TBL] [Abstract][Full Text] [Related]
18. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
Junggren IL; Zhao X; Sun X; Hedner T
J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated hypotensive effect of vascular endothelial growth factor in spontaneously hypertensive rats.
Yang R; Ogasawara AK; Zioncheck TF; Ren Z; He GW; DeGuzman GG; Pelletier N; Shen BQ; Bunting S; Jin H
Hypertension; 2002 Mar; 39(3):815-20. PubMed ID: 11897770
[TBL] [Abstract][Full Text] [Related]
20. Carotid arterial changes produced by a centrally mediated antihypertensive agent in hypertensive rats.
Levy BI; Dabire H; Poitevin P; Safar ME
J Cardiovasc Pharmacol; 1995 Oct; 26(4):666-73. PubMed ID: 8569231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
